Smart Pill is an ingestible capsule that measures pressure, pH and temperature as it travels through the gastrointestinal (GI) tract to assess GI motility. The monitoring can be performed at any clinical office with ease to detect motility disorders, if any.
These are ingestible medical devices consisting of intelligent devices such as sensors, cameras, trackers that help in better monitoring and diagnostics. The capsules can be easily swallowed and are harmless and above all, offers a thorough examination of the gastrointestinal tract detecting the disorders like gastroparesis (a condition in which the contents of the stomach empty too slowly) and chronic constipation.
Download free Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10065095
The smart pill technology has greatly revolutionized the field of gastrointestinal diagnosis. These are much likely to replace the traditional techniques like cryotherapy, EMR, endoscopy, etc. The technology which seemed futuristic and improbable a hundred years ago, is now becoming a reality and is developing a potential market. The idea of a minute pill which can track any potential illness has widely appealed to many people which has further opened new doors for further research on smart pills.
The market is highly segmented into four categories: patient monitoring systems, smart pill drug delivery modes, capsule endoscopy, and diagnostics. The capsule endoscopy is noninvasive and causes minimal discomfort. The magnification obtained, here is of the order 1:8, which is much higher as compared to other methods.
The market is widely divided demographically, North America, Europe, Asia, and Rest of the World (RoW: Pacific countries, Africa, and Latin America) also grant themselves a dominant market share. The North American market highly dominates the global smart pills market which owes to the favorable reimbursement scenario from the state and other approvals for smart pills technology-based products.
Some of the major players in the market include MicroChips, CapsoVision, Inc., Olympus Corporation, Phillips, Vitality, Novartis AG, Proteus Pharmaceuticals, Pixie Scientific, etc.
The report contains comprehensive analysis on:
Smart pills capsule endoscopy Market Segments
Smart pills capsule endoscopy Market Drivers, Restraints and Opportunities
Smart pills capsule endoscopy Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Smart pills capsule endoscopy Market Current Trends
Competition &Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Smart pills capsule endoscopy Market includes
US and Canada
Mexico, Brazil, Argentina and Rest of Latin America
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe
Rest of Eastern Europe
Australia and New Zealand
Rest of Asia Pacific
Request For Full Report: https://www.kennethresearch.com/report-details/global-smart-pills-capsule-endoscopy-market/10065095
Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
Rest of Middle East and Africa
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation.
Phone:+1 313 462 0609